DK1392314T3 - Hidtil ukendt anvendelse af 2-[2-ethoxy-5-(4-methyl-piperazin-1-sulfonyl)-phenyl]-5-methyl-7-propyl-3H-imidazo[5,1-f][1,2,4]-triazin-4-on - Google Patents
Hidtil ukendt anvendelse af 2-[2-ethoxy-5-(4-methyl-piperazin-1-sulfonyl)-phenyl]-5-methyl-7-propyl-3H-imidazo[5,1-f][1,2,4]-triazin-4-onInfo
- Publication number
- DK1392314T3 DK1392314T3 DK02740570T DK02740570T DK1392314T3 DK 1392314 T3 DK1392314 T3 DK 1392314T3 DK 02740570 T DK02740570 T DK 02740570T DK 02740570 T DK02740570 T DK 02740570T DK 1392314 T3 DK1392314 T3 DK 1392314T3
- Authority
- DK
- Denmark
- Prior art keywords
- methyl
- phenyl
- triazin
- imidazo
- piperazine
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Neurology (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10122576 | 2001-05-09 | ||
DE10126198A DE10126198A1 (de) | 2001-05-09 | 2001-05-30 | Neue Verwendung von 2-Phenyl-substituierten Imidazotriazinonen |
PCT/EP2002/005002 WO2002089808A1 (de) | 2001-05-09 | 2002-05-07 | Neue verwendung von 2-phenyl-substituierten imidazotriazinonen |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1392314T3 true DK1392314T3 (da) | 2007-03-12 |
Family
ID=26009261
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK02740570T DK1392314T3 (da) | 2001-05-09 | 2002-05-07 | Hidtil ukendt anvendelse af 2-[2-ethoxy-5-(4-methyl-piperazin-1-sulfonyl)-phenyl]-5-methyl-7-propyl-3H-imidazo[5,1-f][1,2,4]-triazin-4-on |
Country Status (15)
Country | Link |
---|---|
US (1) | US20040152700A1 (zh) |
EP (1) | EP1392314B1 (zh) |
JP (1) | JP4540295B2 (zh) |
CN (1) | CN1633298A (zh) |
AT (1) | ATE348618T1 (zh) |
AU (1) | AU2002314044B2 (zh) |
BR (1) | BR0209541A (zh) |
CA (1) | CA2449163C (zh) |
DE (1) | DE50209015D1 (zh) |
DK (1) | DK1392314T3 (zh) |
ES (1) | ES2278927T3 (zh) |
IL (1) | IL158738A0 (zh) |
MX (1) | MXPA03010119A (zh) |
PL (1) | PL363679A1 (zh) |
WO (1) | WO2002089808A1 (zh) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CU23063A3 (es) * | 1997-11-12 | 2005-07-19 | Bayer Ag | Imidazotriazinonas 2-fenil sustituidas como inhibidores de fosfodiesterasas |
DE10135815A1 (de) * | 2001-07-23 | 2003-02-06 | Bayer Ag | Verwendung von 2-Alkoxyphenyl-substituierten Imidazotriazinonen |
DE10232113A1 (de) * | 2002-07-16 | 2004-01-29 | Bayer Ag | Vardenafil Hydrochlorid Trihydrat enthaltende Arzneimittel |
ATE445402T1 (de) * | 2004-03-05 | 2009-10-15 | Nycomed Gmbh | Neue verwendung von pde5-hemmern |
DE102004023069A1 (de) | 2004-05-11 | 2005-12-08 | Bayer Healthcare Ag | Neue Darreichungsformen des PDE 5-Inhibitors Vardenafil |
DE102004038328A1 (de) * | 2004-08-06 | 2006-03-16 | Bayer Healthcare Ag | Neue Verwendungen von 2-Phenyl-substituierten Imidazotriazinon-Derivaten |
DE102005001989A1 (de) * | 2005-01-15 | 2006-07-20 | Bayer Healthcare Ag | Intravenöse Formulierungen von PDE-Inhibitoren |
DE102005009240A1 (de) * | 2005-03-01 | 2006-09-07 | Bayer Healthcare Ag | Arzneiformen mit verbesserten pharmakokinetischen Eigenschaften |
DE102005009241A1 (de) * | 2005-03-01 | 2006-09-07 | Bayer Healthcare Ag | Arzneiformen mit kontrollierter Bioverfügbarkeit |
JP2009509984A (ja) * | 2005-09-29 | 2009-03-12 | バイエル・ヘルスケア・アクチェンゲゼルシャフト | 泌尿器系障害の処置用のpde阻害剤およびそれらの組合せ |
US8841300B2 (en) | 2006-10-02 | 2014-09-23 | Jerry M. Held | Treatment for Parkinson's disease—combination high dose serotonergic synaptic reuptake inhibitor with phosphodiesterase inhibitor |
JP2010527928A (ja) | 2007-05-18 | 2010-08-19 | ヴィヴァス・インコーポレイテッド | ホスホジエステラーゼ−5阻害剤を含む新規の組み合わせおよびそれらの使用 |
JP2010532319A (ja) * | 2007-06-13 | 2010-10-07 | バイエル・シェーリング・ファルマ・アクチェンゲゼルシャフト | 聴覚障害の処置用のpde阻害剤 |
CN101965348B (zh) * | 2007-09-06 | 2013-11-13 | 上海特化医药科技有限公司 | 伐地那非的制备方法及其中间体 |
EP2929886B1 (en) * | 2012-12-04 | 2021-11-24 | Aribio Inc. | Composition comprising phosphodiesterase type 5 inhibitor for inhibiting apoptosis of nerve cells |
JP2022509815A (ja) | 2018-11-28 | 2022-01-24 | トパデュール ファルマ アーゲー | 新規の二重作用型可溶性グアニル酸シクラーゼ活性化剤およびホスホジエステラーゼ阻害剤とその使用法 |
CN113493459B (zh) * | 2020-04-07 | 2022-12-13 | 广州白云山医药集团股份有限公司白云山制药总厂 | Pde5抑制剂化合物及其制备方法和应用 |
Family Cites Families (55)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2705715A (en) * | 1952-10-29 | 1955-04-05 | American Cyanamid Co | Purine compounds and methods of preparing the same |
CH367510A (de) * | 1957-11-27 | 1963-02-28 | Ciba Geigy | Verfahren zur Herstellung neuer Sulfonamide |
US3169129A (en) * | 1963-05-10 | 1965-02-09 | American Cyanamid Co | 2-ortho-hydroxy-phenyl-4-(3h)-quinazolinones |
US3333840A (en) * | 1964-11-30 | 1967-08-01 | Harbison Walker Refractories | Method of lining a metallurgical furnace and the product thereof |
USRE26565E (en) * | 1966-03-02 | 1969-04-29 | Table iii | |
GB1493685A (en) * | 1970-12-15 | 1977-11-30 | May & Baker Ltd | 8-azapurinones |
BE791025A (fr) * | 1971-11-19 | 1973-05-07 | Allen & Hanburys Ltd | Composes heterocycliques |
GB1457873A (en) * | 1973-01-04 | 1976-12-08 | Allen & Hanburys Ltd | Imidazotriazines |
US4052390A (en) * | 1973-06-12 | 1977-10-04 | May & Baker Limited | Azapurinones |
US4060615A (en) * | 1976-02-18 | 1977-11-29 | Mead Johnson & Company | 2-Piperazinyl-6,7-dimethoxyquinazolines |
GB1561345A (en) * | 1976-10-22 | 1980-02-20 | May & Baker Ltd | 8 - azapuring - 6 - ones |
US4159330A (en) * | 1976-11-02 | 1979-06-26 | Carlo Erba S.P.A. | 2-Disubstituted phenyl-3,4-dihydro-4-oxo-quinazoline derivatives and process for their preparation |
DK109578A (da) * | 1977-03-25 | 1978-09-26 | Allen & Hanburys Ltd | Fremgangsmaade til fremstilling af heterocycliske forbindelser |
DE3166627D1 (en) * | 1980-12-12 | 1984-11-15 | Thomae Gmbh Dr K | Pyrimidones, their preparation and medicines containing them |
US4431440A (en) * | 1981-02-20 | 1984-02-14 | American Cyanamid Company | Method to alter or control the development and/or the life cycle of various plant species |
JPS61237112A (ja) * | 1985-04-12 | 1986-10-22 | Matsushita Electric Works Ltd | 電気機器の電力制御回路 |
CA1303037C (en) * | 1987-02-02 | 1992-06-09 | Smith Kline & French Laboratories Limited | Purinone derivatives as bronchodilators vasodilators and anti-allergic agents |
US5254571A (en) * | 1988-04-21 | 1993-10-19 | Smith Kline & French Laboratories Ltd. | Chemical compounds |
DE68908786T2 (de) * | 1988-06-16 | 1994-03-17 | Smith Kline French Lab | Condensierte Pyrimidinderivate, Verfahren und Zwischenprodukte zu ihrer Herstellung und diese enthaltende pharmazeutische Zubereitungen. |
US5075310A (en) * | 1988-07-01 | 1991-12-24 | Smith Kline & French Laboratories, Ltd. | Pyrimidone derivatives as bronchodilators |
US4923874A (en) * | 1988-07-21 | 1990-05-08 | G. D. Searle & Co. | Use of 8-azapurin-6-one derivatives for control of hypertension |
GB8817651D0 (en) * | 1988-07-25 | 1988-09-01 | Smith Kline French Lab | Chemical compounds |
GB8827988D0 (en) * | 1988-11-30 | 1989-01-05 | Smith Kline French Lab | Chemical compounds |
US5574020A (en) * | 1989-09-28 | 1996-11-12 | Eli Lilly And Company | Tilmicosin formulation |
JPH05506011A (ja) * | 1990-04-11 | 1993-09-02 | ジ・アップジョン・カンパニー | 流動床コーティングによるイブプロフェンの味覚マスキング |
US5250534A (en) * | 1990-06-20 | 1993-10-05 | Pfizer Inc. | Pyrazolopyrimidinone antianginal agents |
GB9114760D0 (en) * | 1991-07-09 | 1991-08-28 | Pfizer Ltd | Therapeutic agents |
US5316906A (en) * | 1991-08-23 | 1994-05-31 | Molecular Probes, Inc. | Enzymatic analysis using substrates that yield fluorescent precipitates |
GB9126260D0 (en) * | 1991-12-11 | 1992-02-12 | Pfizer Ltd | Therapeutic agents |
US5294612A (en) * | 1992-03-30 | 1994-03-15 | Sterling Winthrop Inc. | 6-heterocyclyl pyrazolo [3,4-d]pyrimidin-4-ones and compositions and method of use thereof |
US5734053A (en) * | 1992-06-26 | 1998-03-31 | Pfizer Inc | Purinone antianginal agents |
GB9218322D0 (en) * | 1992-08-28 | 1992-10-14 | Pfizer Ltd | Therapeutic agents |
US6143746A (en) * | 1994-01-21 | 2000-11-07 | Icos Corporation | Tetracyclic cyclic GMP-specific phosphodiesterase inhibitors, process of preparation and use |
US5556847A (en) * | 1994-10-27 | 1996-09-17 | Duquesne University Of The Holy Ghost | Methods of effecting memory enhancement mediated by steroid sulfatase inhibitors |
GB9423911D0 (en) * | 1994-11-26 | 1995-01-11 | Pfizer Ltd | Therapeutic agents |
US6548490B1 (en) * | 1997-10-28 | 2003-04-15 | Vivus, Inc. | Transmucosal administration of phosphodiesterase inhibitors for the treatment of erectile dysfunction |
DE19812462A1 (de) * | 1998-03-23 | 1999-09-30 | Bayer Ag | 2-[2-Ethoxy-5(4-ethyl-piperazin-1-sulfonyl) -phenyl]-5-methyl-7-prophyl-3H-imidazo[5,1-f][1,2,4]triazin-4-on Dihydrochlorid |
CU23063A3 (es) * | 1997-11-12 | 2005-07-19 | Bayer Ag | Imidazotriazinonas 2-fenil sustituidas como inhibidores de fosfodiesterasas |
US6221402B1 (en) * | 1997-11-20 | 2001-04-24 | Pfizer Inc. | Rapidly releasing and taste-masking pharmaceutical dosage form |
GT199900061A (es) * | 1998-05-15 | 2000-10-14 | Pfizer | Formulaciones farmaceuticas. |
DE19827640A1 (de) * | 1998-06-20 | 1999-12-23 | Bayer Ag | 7-Alkyl- und Cycloalkyl-substituierte Imidazotriazinone |
WO2000025292A1 (en) * | 1998-10-27 | 2000-05-04 | Koninklijke Philips Electronics N.V. | Driving a matrix display panel |
US6075028A (en) * | 1999-09-23 | 2000-06-13 | Graham; Richard | Method of treating Tourette's syndrome and related CNS disorders |
GB9923968D0 (en) * | 1999-10-11 | 1999-12-15 | Pfizer Ltd | Therapeutic agents |
CA2323008C (en) * | 1999-10-11 | 2005-07-12 | Pfizer Inc. | Pharmaceutically active compounds |
JP2003519150A (ja) * | 1999-12-24 | 2003-06-17 | バイエル アクチェンゲゼルシャフト | 新規なイミダゾ[1,3,5]トリアジノン類及びその使用 |
CA2406947A1 (en) * | 2000-04-19 | 2001-10-25 | Johns Hopkins University | Methods for prevention and treatment of gastrointestinal disorders |
JP2004505054A (ja) * | 2000-08-01 | 2004-02-19 | バイエル アクチェンゲゼルシャフト | 知覚を改善する医薬品としての選択的pde2インヒビター |
WO2002036126A1 (en) * | 2000-10-30 | 2002-05-10 | Lupin Limited | Rapidly disintegrating sustained release cefuroxime axetil composition |
AU2002230217B2 (en) * | 2001-02-15 | 2005-02-17 | Tanabe Seiyaku Co., Ltd. | Tablets quickly disintegrated in oral cavity |
DE10118306A1 (de) * | 2001-04-12 | 2002-10-17 | Bayer Ag | Imidazotriazinonhaltige Zusammensetzungen zur nasalen Applikation |
US7939102B2 (en) * | 2002-06-07 | 2011-05-10 | Torrent Pharmaceuticals Ltd. | Controlled release formulation of lamotrigine |
DE10232113A1 (de) * | 2002-07-16 | 2004-01-29 | Bayer Ag | Vardenafil Hydrochlorid Trihydrat enthaltende Arzneimittel |
DE10325813B4 (de) * | 2003-06-06 | 2007-12-20 | Universitätsklinikum Freiburg | Prophylaxe und/oder Therapie bei der portalen Hypertonie |
DE102004023069A1 (de) * | 2004-05-11 | 2005-12-08 | Bayer Healthcare Ag | Neue Darreichungsformen des PDE 5-Inhibitors Vardenafil |
-
2002
- 2002-05-07 IL IL15873802A patent/IL158738A0/xx unknown
- 2002-05-07 EP EP02740570A patent/EP1392314B1/de not_active Expired - Lifetime
- 2002-05-07 WO PCT/EP2002/005002 patent/WO2002089808A1/de active IP Right Grant
- 2002-05-07 PL PL02363679A patent/PL363679A1/xx not_active Application Discontinuation
- 2002-05-07 BR BR0209541-6A patent/BR0209541A/pt not_active IP Right Cessation
- 2002-05-07 AU AU2002314044A patent/AU2002314044B2/en not_active Ceased
- 2002-05-07 AT AT02740570T patent/ATE348618T1/de not_active IP Right Cessation
- 2002-05-07 DK DK02740570T patent/DK1392314T3/da active
- 2002-05-07 CN CNA028139267A patent/CN1633298A/zh active Pending
- 2002-05-07 CA CA2449163A patent/CA2449163C/en not_active Expired - Fee Related
- 2002-05-07 ES ES02740570T patent/ES2278927T3/es not_active Expired - Lifetime
- 2002-05-07 JP JP2002586943A patent/JP4540295B2/ja not_active Expired - Fee Related
- 2002-05-07 DE DE50209015T patent/DE50209015D1/de not_active Expired - Lifetime
- 2002-05-07 US US10/476,939 patent/US20040152700A1/en not_active Abandoned
- 2002-05-07 MX MXPA03010119A patent/MXPA03010119A/es unknown
Also Published As
Publication number | Publication date |
---|---|
IL158738A0 (en) | 2004-05-12 |
ATE348618T1 (de) | 2007-01-15 |
CA2449163C (en) | 2010-07-13 |
PL363679A1 (en) | 2004-11-29 |
WO2002089808A1 (de) | 2002-11-14 |
EP1392314A1 (de) | 2004-03-03 |
MXPA03010119A (es) | 2005-03-07 |
DE50209015D1 (de) | 2007-02-01 |
ES2278927T3 (es) | 2007-08-16 |
JP4540295B2 (ja) | 2010-09-08 |
EP1392314B1 (de) | 2006-12-20 |
CA2449163A1 (en) | 2002-11-14 |
JP2004528363A (ja) | 2004-09-16 |
AU2002314044B2 (en) | 2006-09-21 |
US20040152700A1 (en) | 2004-08-05 |
BR0209541A (pt) | 2004-04-20 |
CN1633298A (zh) | 2005-06-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1392314T3 (da) | Hidtil ukendt anvendelse af 2-[2-ethoxy-5-(4-methyl-piperazin-1-sulfonyl)-phenyl]-5-methyl-7-propyl-3H-imidazo[5,1-f][1,2,4]-triazin-4-on | |
EP1432714A4 (en) | CHEMICAL COMPOUNDS | |
DK0765327T3 (da) | Pyrazolo- og pyrrolopyridiner | |
BG108269A (en) | Pyrazolopyrimidines as therapeutic agents | |
DE60114580D1 (de) | Verwendung von cyanochinolinen zur behandlung oder inhibierung von dickdarmpolypen | |
DE60204217D1 (de) | Verwendung von bioglas | |
HUP0402396A2 (hu) | Aszkomicintartalmú, a szem kezelésére szolgáló készítmények | |
ATE429228T1 (de) | Derivate von piperazine-2-carboxamide | |
DE50208918D1 (de) | 6-aminomorphinanderivate, herstellungsverfahren dafür und deren verwendung | |
PL374551A1 (en) | 2-heteroaryl carboxamides | |
TNSN04138A1 (fr) | Metabolites de l'acide (3-{[4-tertiobutylbenzyl)-(pyridine-3-sulfonyl)-amino] - methyl}-phenoxy)-acetique | |
ATE366045T1 (de) | Verwendung von 4-aminopyrimidinen zur antimikrobiellen behandlung von oberflächen | |
MY139368A (en) | Novel cyclohexyl sulphones | |
DE60206289D1 (de) | Verwendung von bibn4096 in kombination mit anderen migränemitteln zur behandlung von migräne | |
PT1140113E (pt) | Utilizacao de bisfosfonatos para profilaxia e tratamento de processos infecciosos | |
DE60033207D1 (de) | Werkzeug zur herstellung von nockenwellen durch einwalzen | |
DE60208701D1 (de) | Verwendung von cetrorelix zur behandlung vom jakob-creutzfeldt-syndrom | |
EA200400751A1 (ru) | Применение дезоксипеганина для лечения клинической депрессии | |
ATE359808T1 (de) | Verwendung von sarp-1 zur behandlung und/oder vorbeugung von scleroderma | |
DE69838686D1 (de) | Tripeptidylpeptidaseinhibitoren | |
ATE279189T1 (de) | Verwendung von 5-aminolävulinsäure zur restenose- prophylaxe | |
AU2003246728A1 (en) | Calcium lactate and whey permeate for lowering the triglyceride level | |
UY26930A1 (es) | Amidas de ácido fenilciclohexanocarboxílico sustituido y su uso | |
ID27656A (id) | Turunan azabisikloheptana n-tersubstitusi, pembuatan dan penggunaannya | |
ATE359088T1 (de) | Verwendung von interleukin-18 zur behandlung von uv-assoziierten hautkrankheiten |